Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by qwen3.7-flash, 2026-08-14

This study found that endometriotic epithelia exhibit significantly lower SRC-1 expression compared to eutopic endometria, particularly during the proliferative phase, suggesting that reduced SRC-1 levels contribute to the limited growth activity of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-14 · read from full text

This study investigated steroid hormone-induced growth mechanisms by comparing the expression of receptor cofactors in 37 cases of ovarian endometriotic epithelia with their patients' eutopic endometria. While estrogen and progesterone receptor levels were similar between the two tissues, Ki-67 proliferation indices were significantly lower in endometriosis, coinciding with a lack of cyclic SRC-1 variation and reduced SRC-1 expression during the proliferative phase. The authors concluded that this down-regulated SRC-1 expression contributes to the limited proliferative activity observed in endometriotic epithelial cells. This paper is centrally about endometriosis — specifically examining molecular drivers of lesion growth in ovarian endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

To study the steroid hormone-induced growth mechanisms of endometriosis, the immunohistochemical expression of steroid hormone receptor cofactors was investigated in 37 cases of endometriotic epithelia and was compared with that of eutopic endometria of identical patients. The expression of steroid receptor coactivators (p300/CBP and SRC-1) and corepressors (NCoR and SMRT) was examined in relation to the estrogen receptor (ER), the progesterone receptor (PR), and Ki-67. Results of immunostaining were indicated as a "positivity index" (PI, full score; 100). The expression of ER and PR in endometriotic epithelia largely resembled that in eutopic endometria, however, the expression of Ki-67 in the proliferative phase (PI 13.8 +/- 2.4, mean +/- SD) was significantly lower than that in eutopic endometria (32.6 +/- 10.6). The expression of SRC-1 in eutopic endometria was increased in the proliferative phase (56.5 +/- 16.8) and decreased in the secretory phase (14.8 +/- 6.9). In endometriosis, however, the PI for SRC-1 did not show apparent cyclic changes during the menstrual cycle. Moreover, the expression of SRC-1 in endometriotic epithelia in the proliferative phase was significantly lower than that in eutopic endometria. These findings suggested the reduced proliferative activity in endometriotic epithelia to be related to the reduced expression of SRC-1.
Full text 9,110 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

To study the steroid hormone-induced growth mechanisms of endometriosis, the immunohistochemical expression of steroid hormone receptor cofactors was investigated in 37 cases of endometriotic epithelia and was compared with that of eutopic endometria of identical patients. The expression of steroid receptor coactivators (p300/CBP and SRC-1) and corepressors (NCoR and SMRT) was examined in relation to the estrogen receptor (ER), the progesterone receptor (PR), and Ki-67. Results of immunostaining were indicated as a “positivity index” (PI, full score; 100). The expression of ER and PR in endometriotic epithelia largely resembled that in eutopic endometria, however, the expression of Ki-67 in the proliferative phase (PI 13.8 ± 2.4, mean ± SD) was significantly lower than that in eutopic endometria (32.6 ± 10.6). The expression of SRC-1 in eutopic endometria was increased in the proliferative phase (56.5 ± 16.8) and decreased in the secretory phase (14.8 ± 6.9). In endometriosis, however, the PI for SRC-1 did not show apparent cyclic changes during the menstrual cycle. Moreover, the expression of SRC-1 in endometriotic epithelia in the proliferative phase was significantly lower than that in eutopic endometria. These findings suggested the reduced proliferative activity in endometriotic epithelia to be related to the reduced expression of SRC-1. Similar content being viewed by others

References

Strauss J III, Coutifaris C (1999) The endometrium and myometrium: regulation and dysfunction. In: Yen SSC, Jaffe RB, Barbieri R (eds) Reproductive endocrinology, 4th edn. WB Saunders, Philadelphia, pp 218–256 Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799 Matsuzaki S, Fukaya T, Suzuki T et al (1999) Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 5:559–564 Giudice LC (1994) Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61:1–17 Shiozawa T, Li SF, Nakayama K et al (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 2:745–752 Shiozawa T, Miyamoto T, Kashima H et al (2004) Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 23:8603–8610 Kashima H, Horiuchi A, Uchikawa J et al (2009) Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma. Anticancer Res 29:1023–1029 McKenna NJ, Lanz RB, O’Malley BW (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321–344 McKenna NJ, O’Malley BW (2000) From ligand to response: generating diversity in nuclear receptor coregulator function. J Steroid Biochem Mol Biol 74:351–356 Shiozawa T, Shih HC, Miyamoto T et al (2003) Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 88:871–878 Uchikawa J, Shiozawa T, Shih HC et al (2003) Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 98:2207–2213 Freedman LP (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97:5–8 Huang HJ, Norris JD, McDonnell DP (2002) Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 16:1778–1792 Pickartz H, Beckmann R, Fleige B et al (1990) Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Arch A Pathol Anat Histopathol 417:163–171 Jones RK, Bulmer JN, Searle RF (1995) Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 10:3272–3279 Nisolle M, Casanas-Roux F, Donnez J (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68:912–919 Mosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53 Fujimoto J, Hirose R, Sakaguchi H et al (1999) Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod 5:742–747 Brandenberger AW, Lebovic DI, Tee MK et al (1999) Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 5:651–655 Misiti S, Schomburg L, Yen PM et al (1998) Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139:2493–2500 Klinge CM, Jernigan SC, Mattingly KA et al (2004) Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 33:387–410 Leo C, Chen JD (2000) The SRC family of nuclear receptor coactivators. Gene 245:1–11 Spencer TE, Jenster G, Burcin MM et al (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194–198 Tai H, Kubota N, Kato S (2000) Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells. Biochem Biophys Res Commun 267:311–316 Thenot S, Charpin M, Bonnet S et al (1999) Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156:85–93 Nephew KP, Ray S, Hlaing M et al (2000) Expression of estrogen receptor coactivators in the rat uterus. Biol Reprod 63:361–367 Noble LS, Simpson ER, Johns A et al (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174–179 Zeitoun K, Takayama K, Sasano H et al (1998) Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83:4474–4480 Leite RS, Brown AG, Strauss JF III (2004) Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness. FASEB J 18:1418–1420 Eisermann J, Gast MJ, Pineda J et al (1988) Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 50:573–579 Shibata H, Spencer TE, Onate SA et al (1997) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141–164, discussion 16 Kwok RP, Lundblad JR, Chrivia JC et al (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223–226 Zhang X, Jeyakumar M, Petukhov S et al (1998) A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12:513–524 Zanger K, Radovick S, Wondisford FE (2001) CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol Cell 7:551–558 Zhong H, May MJ, Jimi E et al (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625–636 Wieser F, Schneeberger C, Hudelist G et al (2002) Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol Hum Reprod 8:644–650 Metzger DA, Olive DL, Haney AF (1988) Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium. Hum Pathol 19:1417–1424 Bulun SE, Cheng YH, Yin P et al (2006) Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248:94–103 Wagner BL, Norris JD, Knotts TA et al (1998) The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18:1369–1378 Wang D, Wang Q, Awasthi S et al (2007) Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors. Biochemistry 46:8036–8049 Acknowledgment Conflict of interest statement We declare that we have no conflict of interest. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Suzuki, A., Horiuchi, A., Oka, K. et al. Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium. Virchows Arch 456, 433–441 (2010). https://doi.org/10.1007/s00428-010-0884-x Received: Revised: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00428-010-0884-x

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Cell Proliferation Endometriosis Epithelial Cells Nuclear Receptor Coactivator 1 Ovarian Diseases Receptors, Estrogen Receptors, Progesterone Adult Co-Repressor Proteins Co-Repressor Proteins Down-Regulation Endometriosis Endometriosis Epithelial Cells Epithelial Cells Female Humans Ki-67 Antigen Ki-67 Antigen Middle Aged

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Source provenance

crossref
last seen: 2026-05-20T01:00:26.115234+00:00
europepmc
last seen: 2026-09-12T06:55:35.949492+00:00
pubmed
last seen: 2026-05-13T22:17:18.915199+00:00
unpaywall
last seen: 2026-09-12T07:21:10.926195+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine